News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,103 Results
Type
Article (42717)
Company Profile (294)
Press Release (670092)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (207573)
Career Advice (2254)
Deals (35874)
Drug Delivery (100)
Drug Development (82140)
Employer Resources (179)
FDA (16293)
Job Trends (15127)
News (350611)
Policy (33064)
Tag
Academia (2635)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50534)
ALS (94)
Alzheimer's disease (1400)
Antibody-drug conjugate (ADC) (129)
Approvals (16293)
Artificial intelligence (263)
Autoimmune disease (21)
Automation (16)
Bankruptcy (366)
Best Places to Work (11759)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (217)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (281)
Cancer (2295)
Cardiovascular disease (182)
Career advice (1884)
Career pathing (31)
CAR-T (156)
Cell therapy (440)
Cervical cancer (19)
Clinical research (66774)
Collaboration (857)
Company closure (1)
Compensation (534)
Complete response letters (21)
COVID-19 (2646)
CRISPR (42)
C-suite (248)
Cystic fibrosis (100)
Data (2223)
Decentralized trials (2)
Denatured (19)
Depression (47)
Diabetes (274)
Diagnostics (6458)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (87268)
Editorial (44)
Employer branding (21)
Employer resources (152)
Events (115554)
Executive appointments (737)
FDA (17568)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (108)
Generative AI (21)
Gene therapy (316)
GLP-1 (731)
Government (4476)
Grass and pollen (4)
Guidances (67)
Healthcare (19034)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (121)
Indications (30)
Infectious disease (2791)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (99)
Interviews (376)
IPO (16662)
IRA (42)
Job creations (3785)
Job search strategy (1595)
Kidney cancer (11)
Labor market (38)
Layoffs (477)
Leadership (19)
Legal (8051)
Liver cancer (75)
Lung cancer (324)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (318)
MASH (67)
Medical device (13442)
Medtech (13447)
Mergers & acquisitions (19756)
Metabolic disorders (702)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1952)
NextGen: Class of 2025 (6634)
Non-profit (4540)
Now hiring (39)
Obesity (375)
Opinion (234)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (238)
Patient recruitment (114)
Peanut (47)
People (58559)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20878)
Phase II (29440)
Phase III (21815)
Pipeline (1213)
Policy (143)
Postmarket research (2583)
Preclinical (8914)
Press Release (71)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (388)
Real estate (6111)
Recruiting (70)
Regulatory (22639)
Reports (46)
Research institute (2394)
Resumes & cover letters (374)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (131)
Series B (88)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3708)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (31)
Vaccines (703)
Venture capitalists (43)
Weight loss (246)
Women's health (35)
Worklife (16)
Date
Last 7 days (906)
Last 30 days (2522)
Last 365 days (33127)
2025 (10931)
2024 (35740)
2023 (40537)
2022 (51754)
2021 (56257)
2020 (54672)
2019 (47212)
2018 (35603)
2017 (32778)
2016 (32324)
2015 (38253)
2014 (32030)
2013 (27105)
2012 (29396)
2011 (30039)
2010 (28091)
Location
Africa (783)
Alabama (53)
Alaska (7)
Arizona (237)
Arkansas (13)
Asia (39055)
Australia (6535)
California (6212)
Canada (2022)
China (533)
Colorado (270)
Connecticut (279)
Delaware (150)
Europe (84727)
Florida (913)
Georgia (209)
Idaho (57)
Illinois (566)
India (25)
Indiana (309)
Iowa (11)
Japan (164)
Kansas (108)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (902)
Massachusetts (4647)
Michigan (221)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1754)
New Mexico (30)
New York (1761)
North Carolina (996)
North Dakota (9)
Northern California (2713)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1393)
Puerto Rico (12)
Rhode Island (33)
South America (1170)
South Carolina (23)
South Dakota (1)
Southern California (2327)
Tennessee (102)
Texas (917)
United States (23461)
Utah (183)
Virginia (150)
Washington D.C. (63)
Washington State (562)
West Virginia (3)
Wisconsin (55)
713,103 Results for "turn biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing agreement with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
May 28, 2024
·
7 min read
Biotech Bay
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies
Turn Biotechnologies announced an exclusive global licensing agreement with pharmaceutical manufacturer HanAll Biopharma to develop groundbreaking medicines for the treatment of age-related eye and ear conditions.
May 28, 2024
·
4 min read
Biotech Bay
Turn Biotechnologies Discussed Emerging Therapies at Aesthetic Plastic Surgery Society Meeting
Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, presented its breakthrough research and therapies to treat age-related diseases to members of the American Society for Aesthetic Plastic Surgery, known as The Aesthetic Society.
May 7, 2024
·
2 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
Equipment Junction Turns Surplus Lab Gear into STEM Opportunities
April 1, 2025
·
1 min read
Press Releases
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours
May 2, 2025
·
2 min read
Job Trends
Difficult Market Turns More Biopharma Leaders to Fractional Roles, Say Experts
For reasons including downsizing, avoiding retirement and a tight labor market, senior-level biopharma professionals are increasingly turning to fractional roles, according to two recruitment experts.
August 28, 2024
·
4 min read
·
Angela Gabriel
Press Releases
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
April 24, 2025
·
4 min read
Press Releases
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
April 23, 2025
·
6 min read
Biotech Bay
Turn Biotechnologies’ Expands eTurna™ Delivery Platform to Solve Delivery and Targeting Issues that Challenge Industry
Turn Biotechnologies announced the expansion of its eTurna™ delivery platform that is expected to overcome the greatest challenge to breakthrough therapies: The safe and efficient targeting of specific organs and cells.
January 3, 2024
·
2 min read
1 of 71,311
Next
